title: Beta 1 integrin expression in adenocarcinoma of Barrett's esophagus.
abstract: OBJECTIVE
  In vitro and in vivo studies did not show that beta 1 integrin expression is associated with malignant transformation or that it is of prognostic value in some malignant tumors. There are no data on the expression or prognostic value of beta 1 integrins in adenocarcinoma of Barrett's esophagus.
  
  
  METHODS
  We assessed the expression pattern and the prognostic impact of beta 1 integrins in paraffin-embedded specimens of 41 patients with adenocarcinoma of Barrett's esophagus by immunochemistry. At the time of investigation, neither histomorphological parameters nor the survival time were known.
  
  
  RESULTS
  There was no correlation between histomorphological parameters and the expression of beta 1 integrins. The expression of beta 1 integrins had no influence on long- term survival. There was a relationship between the prognosis and the following histopathological parameters: pT, pN and pM category, the UICC stage, the presence of lymphangiosis, and the DNA content of the tumor cells.
  
  
  CONCLUSIONS
  The preliminary results obtained in this study did not show that the expression of beta 1 integrins was of prognostic value in patients with adenocarcinoma of Barrett's esophagus. Further studies in a larger number of patients are required to confirm the results obtained in this investigation.
authors.affiliation: Department of Surgery, Johannes Gutenberg University Mainz, Germany. boettger@allgemchir.klinik.uni-mainz.de
authors.forename: T C
authors.initials: TC
authors.lastname: Bottger
authors.forename: V
authors.initials: V
authors.lastname: Youssef
authors.forename: P
authors.initials: P
authors.lastname: Dutkowski
authors.forename: J
authors.initials: J
authors.lastname: Seifert
authors.forename: H
authors.initials: H
authors.lastname: Maschek
authors.forename: W
authors.initials: W
authors.lastname: Brenner
authors.forename: T
authors.initials: T
authors.lastname: Junginger
mesh_terms: D000230:Adenocarcinoma / Q000235:genetics* / Q000401:mortality / Q000473:pathology; D000328:Adult; D000368:Aged; D001471:Barrett Esophagus / Q000235:genetics* / Q000401:mortality / Q000473:pathology; D002471:Cell Transformation, Neoplastic / Q000235:genetics / Q000473:pathology; D004938:Esophageal Neoplasms / Q000235:genetics* / Q000401:mortality / Q000473:pathology; D005260:Female; D005500:Follow-Up Studies; D015972:Gene Expression Regulation, Neoplastic / Q000502:physiology; D006801:Humans; D019012:Integrin beta1 / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011230:Precancerous Conditions / Q000235:genetics* / Q000401:mortality / Q000473:pathology; D015996:Survival Rate
chemical_list: D019012:Integrin beta1